Rocket Pharmaceuticals Inc (RCKT)

Jun 5, 2025, 10:00 AM EDT - 13 hours ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Rocket Pharmaceuticals, Inc. (RCKT) And Encourages Investors to Connect

Jun 4, 2025, 10:00 AM EDT - 1 day ago

Bronstein, Gewirtz & Grossman, LLC Encourages Rocket Pharmaceuticals, Inc. (RCKT) Stockholders to Inquire about Securities Investigation

Jun 3, 2025, 10:00 AM EDT - 2 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Rocket Pharmaceuticals, Inc. (RCKT) and Encourages Investors to Learn More About the Investigation

Jun 2, 2025, 10:00 AM EDT - 3 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Rocket Pharmaceuticals, Inc. (RCKT) and Encourages Stockholders to Learn More About the Investigation

Jun 1, 2025, 10:00 AM EDT - 4 days ago

Bronstein, Gewirtz & Grossman, LLC Encourages Rocket Pharmaceuticals, Inc. (RCKT) Investors to Inquire about Securities Investigation

May 30, 2025, 10:00 AM EDT - 6 days ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Rocket Pharmaceuticals, Inc. (RCKT) And Encourages Investors to Reach Out

May 29, 2025, 6:44 PM EDT - 7 days ago

Rocket Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law Firm

May 29, 2025, 10:00 AM EDT - 7 days ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Rocket Pharmaceuticals, Inc. (RCKT) And Encourages Stockholders to Reach Out

May 28, 2025, 3:35 PM EDT - 8 days ago

Rocket Pharma's Gene Therapy Future Clouded By Regulatory Uncertainty

May 28, 2025, 3:15 PM EDT - 8 days ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Rocket Pharmaceuticals, Inc. (RCKT) And Encourages Stockholders to Connect

May 28, 2025, 8:22 AM EDT - 8 days ago

These Analysts Slash Their Forecasts On Rocket Pharmaceuticals

May 27, 2025, 11:07 AM EDT - 9 days ago

Rocket Pharma Reports Patient Death In Rare Disease Gene Therapy Trial, FDA Puts Clinical Hold

May 27, 2025, 7:00 AM EDT - 9 days ago

Rocket Pharmaceuticals Provides Update on Phase 2 Clinical Trial of RP-A501 for Danon Disease

May 15, 2025, 3:15 PM EDT - 21 days ago

Rocket Pharmaceuticals Presents Preliminary Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy at 28th Annual Meeting of the American Society of Gene and Cell Therapy

May 9, 2025, 4:30 PM EDT - 27 days ago

Rocket Pharmaceuticals Announces Late-Breaking Oral Presentation of Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy Accepted at 28th Annual Meeting of the American Society of Gene and Cell Therapy

May 8, 2025, 4:01 PM EDT - 4 weeks ago

Rocket Pharmaceuticals Reports First Quarter 2025 Financial Results and Highlights Recent Progress

Apr 10, 2025, 11:16 AM EDT - 2 months ago

Rocket Pharma Out Of Orbit, But Ready For Relaunch

Apr 3, 2025, 7:00 AM EDT - 2 months ago

Rocket Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference

Feb 27, 2025, 4:01 PM EST - 3 months ago

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress

Feb 12, 2025, 3:40 PM EST - 4 months ago

Rocket Pharma Is A Buy At These Prices With Promising Data

Jan 6, 2025, 7:19 AM EST - 5 months ago

Top 3 Health Care Stocks That Could Blast Off This Month

INO OTLK

Jan 2, 2025, 4:00 PM EST - 5 months ago

Rocket Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Dec 18, 2024, 3:00 PM EST - 6 months ago

Rocket Pharmaceuticals Stock Soars as Jefferies Initiates Coverage at 'Buy'

Dec 11, 2024, 7:00 AM EST - 6 months ago

Rocket Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

Dec 10, 2024, 4:01 PM EST - 6 months ago

Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock

Nov 26, 2024, 7:00 AM EST - 6 months ago

Rocket Pharmaceuticals to Participate in the 7th Annual Evercore HealthCONx Conference

Nov 19, 2024, 2:47 PM EST - 7 months ago

Rocket Pharmaceuticals' Gene Therapy Progress Boosts Confidence in Future Developments: Analyst

Nov 18, 2024, 11:00 AM EST - 7 months ago

Rocket Pharmaceuticals Announces New England Journal of Medicine Publication of Phase 1 RP-A501 Long-Term Data and Presents at Late-Breaking Scientific Sessions at 2024 American Heart Association Conference

Nov 12, 2024, 4:01 PM EST - 7 months ago

Rocket Pharmaceuticals to Present Updated Data from the Phase 1 Clinical Trial of RP-A501 for Danon Disease at the American Heart Association's 2024 Late-Breaking Science Sessions

Nov 8, 2024, 7:00 AM EST - 7 months ago

Rocket Pharmaceuticals to Participate in the UBS Global Healthcare Conference

Nov 7, 2024, 4:01 PM EST - 7 months ago

Rocket Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Progress

Sep 19, 2024, 3:18 PM EDT - 9 months ago

Rocket: Danon Disease Treatment Program Should Carry The Tide Until Regulatory Moves

Sep 17, 2024, 7:00 AM EDT - 9 months ago

Rocket Pharmaceuticals Announces Completion of Enrollment in Phase 2 Pivotal Trial of RP-A501 for the Treatment of Danon Disease

Sep 10, 2024, 7:00 AM EDT - 9 months ago

Rocket Pharmaceuticals Announces Appointment of Mikael Dolsten, M.D., Ph.D., to Board of Directors

Aug 27, 2024, 7:00 AM EDT - 10 months ago

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences

Aug 5, 2024, 4:01 PM EDT - 10 months ago

Rocket Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Progress

Jul 29, 2024, 3:32 PM EDT - 11 months ago

3 Biotech Names With Potential Catalysts By Year End

CADL VRDN

Jun 28, 2024, 1:26 PM EDT - 1 year ago

FDA Again Delays Approval of Rocket Pharmaceuticals' Gene Therapy Treatment

Jun 28, 2024, 7:27 AM EDT - 1 year ago

Rocket Pharmaceuticals Provides Regulatory Update on KRESLADI™ (marnetegragene autotemcel; marne-cel)